Member Info for chrishutch

interest building here. No doubt we will be having the same convos at 5,6,7,8p+

Sadly I think he just wants a negative thread title trending.

Just confused why your stance went from telling everyone about the huge potential to harping on about working capital needs in a years time...

"
Targeted Lung Health Checks (TLHC) + CIZ = £x millions11 Feb 2022 09:15
NHS Cancer Programme - February 2022

Early Detection and diagnosis of cancer

The NHS Long Term Plan (LTP) sets out stretching ambitions and commitments to improve cancer care outcomes and services in England. The key ambitions are:

- by 2028,55,000 more people each year will survive their cancer for five years or more; and

- by 2028, 75% of people with cancer will be diagnosed at an early stage (stages one or two).

Diagnosing cancer early increases chances of survival as it means patients can receive treatment when there is a better chance of achieving a complete cure…

… The Challenge

The cancer community is making great strides towards delivering the LTP ambition for Early Diagnosis via a number of national programmes. However, there is recognition that this effort needs to go further faster.

The NHS Cancer Programme at NHS England and NHS Improvement (NHSEI) are looking for innovations or new approaches that will increase the proportion of cancers that are diagnosed at stage one or two.

https://sbrihealthcare.co.uk/wp-content/uploads/2022/02/Challenge-brief_Final.pdf

Xref: CIZ RNS

CEO Allan Syms:

"I am also pleased to report that we have commenced a robust health economics exercise to establish that the test satisfies the specific economic requirements and benefits required by the NHS and its patients. We are also investigating additional global strategic alliances in order to facilitate the future commercial acceptance and roll-out of the test worldwide."

https://www.londonstockexchange.com/news-article/CIZ/gm-statement/15036333

NHS TLHC + CIZ = £x millions"

Jigger_1 are you holding stock here?

ADVANTAGES TO THE GOV, Tax payer and private healthcare companies.
+ Huge savings on testing
+Huge savings identifying cancer earlier

ADVANTAGES TO THE HEALTHCARE SYSTEM
+ Freeing up resources
Reducing burden on fixed resources, by freeing up CT scanners
+ Non-invasive
The test could allow for fewer patients needing costly, ultimately futile interventions

ADVANTAGES TO PATIENTS
+ Less radiation
Reduced exposure to radiation due to a reduced need for repeated CT scanning
+ Non-invasive
Relatively non-invasive, involving a small blood sample
+ Convenient
Will not require attending specialist scanning units within hospitals
+ Faster
Reduced waiting times until diagnosis

haha from your constant desire to post negatives, I suspect you mistimed your entry or were one of the people trying to trade it and got locked out.

10p was the IPO price!

Those that bought in there expected to make money over time from that level.

I have had quite a few DMs on twitter asking for more information on CIZ already.

Should be an easy ride upwards from here

I suspect we will see a massive increase in the attention this one gets from here on.

Morning all.

Your welcome. Tell me where do you see the company being by December?

directors talk interviews . com

https://www.***************************/cizzle-biotechnology-azd-1656-deal-means-near-term-revenue-streams-interview/4121052890

It is good that we debate all things and don't just have a one sided view. Happy to hear if you thing I have this or anything to do with the company wrong, Jigger_1.

Hi, I think I outlined my view below, I am not sure what you want me to add to it. It is only my view. I encourage you and others to form your own views so I am grateful that you highlight this, but..

For myself, this is not something I am concerned about, if anything it is positive. CIZ as you say has cash cushion of 10 months which is quite a healthy cushion for a small cap. But even if we shaved two months off would it really matter? It is a tiny amount of working capital that the report refers to.

For this to be a problem we would have to assume they are not going to do anything or their overheads are going to rapidly increase. I don't think the company will remain static and not do anything. I think there will be more partnerships and royalty agreements and I believe we will hear of another fairly soon.

"Through various partnerships and collaborations, Cizzle is aiming to maximise the value of its lung cancer asset. The strategic alliance in China paves the way towards its test becoming available in the largest lung cancer market in the world, at little cost to the company. This deal represents another example of the company expanding its commercial opportunity and potentially accelerating its income streams."

I think if by year end we are debating working cap the price will be a lot higher than where it currently is.

No, they have a lower burn rate, not only are they the first company to come in at 50% of predicted admin costs last year but they have cash, full funding in China, royalties, grants and a desirable product that if successful will have global demand. They will be calling the shots.

The only way I see cash being an issue is should they want to expand at a faster rate than the can comfortably manage, this would involve taking on debt or a partnership rather than raises. If they were to go to the market I expect it to be at multiples of the current SP. They are not keeping the lights on they are lighting up the world.

With companies like CIZ you have to start thinking about what they are trying to achieve.

Once you grasp the enormity of that & the global impact it will have..

You should ask 'Will this company be more or less relevant in 2,3,5 years?

Not 2,3,5 days.